Hasbro, Inc. vs 10X Genomics Inc — how do they compare? Hasbro, Inc. trades at $97.48 (market cap $13.69B), while 10X Genomics Inc trades at $59.24 (market cap $7.61B). The key difference: Hasbro, Inc. is the larger of the two by market cap, and Hasbro, Inc. pays a 2.89% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| HAS | TXG | |
|---|---|---|
Market Cap | $13.69B | $7.61B |
Sector | Consumer Cyclical | Health |
52-Week High | $105.88 | $58.57 |
52-Week Low | $70.95 | $11.34 |
Enterprise Value | $15.88B | $7.14B |
Dividend Yield | 2.89% | — |
Trailing returns across standard periods
Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Nerf, and Magic: The Gathering. Ownership stakes in Discovery Family, which offers programming around Hasbro brands, and owned production capabilities from Entertainment One help bolster Hasbro's multichannel presence. The firm acquired Entertainment One in 2019, bolting on popular properties like Peppa Pig and PJ Masks, and has plans to tie up with Dungeons & Dragons Beyond in 2022, offering the firm access 10 million digital tabletop players.
Read more on HAS →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →